We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comorbidity, Frailty, and Waitlist Mortality among Kidney Transplant Candidates of All Ages.
- Authors
Pérez Fernández, María; Martínez Miguel, Patricia; Ying, Hao; Haugen, Christine E.; Chu, Nadia M.; Rodríguez Puyol, Diego María; Rodríguez-Mañas, Leocadio; Norman, Silas P.; Walston, Jeremy D.; Segev, Dorry L.; McAdams-DeMarco, Mara A.; Pérez Fernández, María; Martínez Miguel, Patricia; Haugen, Christine E; Chu, Nadia M; Rodríguez Puyol, Diego María; Norman, Silas P; Walston, Jeremy D; Segev, Dorry L; McAdams-DeMarco, Mara A
- Abstract
<bold>Background: </bold>Kidney transplantation (KT) candidates often present with multiple comorbidities. These patients also have a substantial burden of frailty, which is also associated with increased mortality. However, it is unknown if frailty is merely a surrogate for comorbidity, itself an independent domain of risk, or if frailty and comorbidity have differential effects. Better understanding the interplay between these 2 constructs will improve clinical decision making in KT candidates.<bold>Objective: </bold>To test whether comorbidity is equally associated with waitlist mortality among frail and nonfrail KT candidates and to test whether measuring both comorbidity burden and frailty improves mortality risk prediction.<bold>Methods: </bold>We studied 2,086 candidates on the KT waitlist (November 2009 - October 2017) in a multicenter cohort study, in whom frailty and comorbidity were measured at evaluation. We quantified the association between Charlson comorbidity index (CCI) adapted for end-stage renal disease and waitlist mortality using an adjusted Cox proportional hazards model and tested whether this association differed between frail and nonfrail candidates.<bold>Results: </bold>At evaluation, 18.1% of KT candidates were frail and 51% had a high comorbidity burden (CCI score ≥2). Candidates with a high comorbidity burden were at 1.38-fold (95% CI 1.01-1.89) increased risk of waitlist mortality. However, this association differed by frailty status (p for interaction = 0.01): among nonfrail candidates, a high comorbidity burden was associated with a 1.66-fold (95% CI 1.17-2.35) increased mortality risk; among frail candidates, here was no statistically significant association (HR 0.75, 95% CI 0.44-1.29). Adding this interaction between comorbidity and frailty to a mortality risk estimation model significantly improved prediction, increasing the c-statistic from 0.640 to 0.656 (p < 0.001).<bold>Conclusions: </bold>Nonfrail candidates with a high comorbidity burden at KT evaluation have an increased risk of waitlist mortality. Importantly, comorbidity is less of a concern in already high-risk patients who are frail.
- Publication
American Journal of Nephrology, 2019, Vol 49, Issue 2, p103
- ISSN
0250-8095
- Publication type
journal article
- DOI
10.1159/000496061